These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13496181)

  • 21. Correlation between proguanil and metabolites in plasma and saliva.
    Alexander C; Nathwani D; Zimbler N; Taylor RB
    J Antimicrob Chemother; 1995 Dec; 36(6):1113-5. PubMed ID: 8821621
    [No Abstract]   [Full Text] [Related]  

  • 22. High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.
    Kaneko A; Kaneko O; Taleo G; Björkman A; Kobayakawa T
    Lancet; 1997 Mar; 349(9056):921-2. PubMed ID: 9093256
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F; Salzman JR; Ensom MH
    Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
    Ndounga M; Basco LK; Ringwald P
    Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
    Wright JD; Helsby NA; Ward SA
    Br J Clin Pharmacol; 1995 Apr; 39(4):441-4. PubMed ID: 7640152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.
    Pang LW; Limsomwong N; Singharaj P; Canfield CJ
    Bull World Health Organ; 1989; 67(1):51-8. PubMed ID: 2706727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modern antimalarial therapy.
    PFEIFFER CC
    Mod Hosp; 1952 Aug; 79(2):106-8. PubMed ID: 12992919
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
    Touze JE; Fourcade L; Pradines B; Hovette P; Paule P; Heno P
    Med Trop (Mars); 2002; 62(3):219-24. PubMed ID: 12244914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial drugs in West Africa, with particular reference to proguanil; results of a survey in Nigeria.
    BRUCE-CHWATT LJ; BRUCE-CHWATT JM
    Br Med J; 1950 Jul; 2(4669):7-14. PubMed ID: 15426791
    [No Abstract]   [Full Text] [Related]  

  • 34. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Color reaction of chlorhexidine and proguanil with hypobromite].
    Görlitzer K; Huth S; Jones PG
    Pharmazie; 2005 Apr; 60(4):269-72. PubMed ID: 15881606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on synthetic antimalarial drugs; the blood concentrations and physiological distribution of some homologues of paludrine in relation to their antimalarial activities.
    SPINKS A
    Ann Trop Med Parasitol; 1948 Sep; 42(2):190-7. PubMed ID: 18891445
    [No Abstract]   [Full Text] [Related]  

  • 37. Transport and binding of chloroguanide-triazine by rat liver slices.
    Gigon PL; Nayak PK; Schanker LS
    Proc Soc Exp Biol Med; 1969 Dec; 132(3):1103-9. PubMed ID: 5360987
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis during chloroguanide prophylaxis.
    Oostweegel LM; Beijnen JH; Mulder JW
    Ann Pharmacother; 1998 Oct; 32(10):1023-5. PubMed ID: 9793594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmaceutical care for international voyagers: prophylaxis including chloroquine plus proguanil].
    Hernández Tintorer JL; Lorduy Osés L
    Farm Hosp; 2004; 28(2):137-40. PubMed ID: 15101806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EXTRAMALARIAL THERAPUETIC APPLICATIONS OF ANTIMALARIAL DRUGS. 1. CLINICAL UTILIZATIONS].
    SULLI G; VARRONE F
    Clin Ter; 1963 Oct; 27():132-68 CONTD. PubMed ID: 14100826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.